Annual Short Term Debt
$3.38 M
+$8000.00+0.24%
31 December 2023
Summary:
Neumora Therapeutics Common Stock annual short term debt is currently $3.38 million, with the most recent change of +$8000.00 (+0.24%) on 31 December 2023. During the last 3 years, it has risen by +$2.32 million (+219.89%). NMRA annual short term debt is now at all-time high.NMRA Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Short Term Debt
$2.75 M
-$862.00 K-23.90%
30 September 2024
Summary:
Neumora Therapeutics Common Stock quarterly short term debt is currently $2.75 million, with the most recent change of -$862.00 thousand (-23.90%) on 30 September 2024. Over the past year, it has dropped by -$633.00 thousand (-18.74%). NMRA quarterly short term debt is now -23.90% below its all-time high of $3.61 million, reached on 30 June 2024.NMRA Quarterly Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NMRA Short Term Debt Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | -18.7% |
| 3 y3 years | +219.9% | +159.9% |
| 5 y5 years | +100.0% | - |
NMRA Short Term Debt High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +219.9% | -23.9% | +163.4% |
| 5 y | 5 years | at high | -23.9% | +259.3% | |
| alltime | all time | at high | -23.9% | +259.3% |
Neumora Therapeutics Common Stock Short Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $2.75 M(-23.9%) |
| June 2024 | - | $3.61 M(+3.3%) |
| Mar 2024 | - | $3.49 M(+3.3%) |
| Dec 2023 | $3.38 M(+0.2%) | $3.38 M(-0.6%) |
| Sept 2023 | - | $3.40 M(+2.3%) |
| June 2023 | - | $3.32 M(-1.4%) |
| Dec 2022 | $3.37 M | $3.37 M(+30.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2022 | - | $2.59 M(+148.7%) |
| Mar 2022 | - | $1.04 M(-1.3%) |
| Dec 2021 | $1.06 M(+38.2%) | - |
| Dec 2021 | - | $1.06 M(-14.1%) |
| Sept 2021 | - | $1.23 M(+60.9%) |
| Dec 2020 | $764.00 K(>+9900.0%) | $764.00 K |
| Dec 2019 | $0.00 | - |
FAQ
- What is Neumora Therapeutics Common Stock annual short term debt?
- What is the all time high annual short term debt for Neumora Therapeutics Common Stock?
- What is Neumora Therapeutics Common Stock quarterly short term debt?
- What is the all time high quarterly short term debt for Neumora Therapeutics Common Stock?
- What is Neumora Therapeutics Common Stock quarterly short term debt year-on-year change?
What is Neumora Therapeutics Common Stock annual short term debt?
The current annual short term debt of NMRA is $3.38 M
What is the all time high annual short term debt for Neumora Therapeutics Common Stock?
Neumora Therapeutics Common Stock all-time high annual short term debt is $3.38 M
What is Neumora Therapeutics Common Stock quarterly short term debt?
The current quarterly short term debt of NMRA is $2.75 M
What is the all time high quarterly short term debt for Neumora Therapeutics Common Stock?
Neumora Therapeutics Common Stock all-time high quarterly short term debt is $3.61 M
What is Neumora Therapeutics Common Stock quarterly short term debt year-on-year change?
Over the past year, NMRA quarterly short term debt has changed by -$633.00 K (-18.74%)